ArticleResearch and practice in thrombosis and haemostasis2026

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up.

Roman Schimmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.